Fig. 6: G-CIMP subgroup, MGMT promoter methylation, and TP53 mutation are significant prognosticators in IDH-mutant primary glioblastomas.
From: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
A OS and B PFS of G-CIMP-high and G-CIMP-low IDH-mutant primary glioblastomas. C OS and D PFS of MGMT promoter methylation in IDH-mutant primary glioblastomas. E OS and F PFS of TP53 mutation in IDH-mutant primary glioblastomas.
